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Abstract
Background: Information on the epidemiology of malaria is essential for designing and interpreting results of clinical trials of
drugs, vaccines and other interventions. As a background to the establishment of a site for anti-malarial drugs and vaccine trials,
the epidemiology of malaria in a rural site in central Ghana was investigated.
Methods: Active surveillance of clinical malaria was carried out in a cohort of children below five years of age (n = 335) and
the prevalence of malaria was estimated in a cohort of subjects of all ages (n = 1484) over a 12-month period. Participants were
sampled from clusters drawn around sixteen index houses randomly selected from a total of about 22,000 houses within the
study area. The child cohort was visited thrice weekly to screen for any illness and a blood slide was taken if a child had a history
of fever or a temperature greater than or equal to 37.5 degree Celsius. The all-age cohort was screened for malaria once every
eight weeks over a 12-month period. Estimation of Entomological Inoculation Rate (EIR) and characterization of Anopheline
malaria vectors in the study area were also carried out.
Results: The average parasite prevalence in the all age cohort was 58% (95% CI: 56.9, 59.4). In children below five years of age,
the average prevalence was 64% (95% CI: 61.9, 66.0). Geometric mean parasite densities decreased significantly with increasing
age. More than 50% of all children less than 10 years of age were anaemic. Children less than 5 years of age had as many as seven
malaria attacks per child per year. The attack rates decreased significantly with increasing cut-offs of parasite density. The
average Multiplicity of Infection (MOI) was of 6.1. All three pyrimethamine resistance mutant alleles of the Plasmodium falciparum
dhfr gene were prevalent in this population and 25% of infections had a fourth mutant of pfdhps-A437G. The main vectors were
Anopheles funestus and Anopheles gambiae and the EIR was 269 infective bites per person per year.
Conclusion: The transmission of malaria in the forest-savanna region of central Ghana is high and perennial and this is an
appropriate site for conducting clinical trials of anti-malarial drugs and vaccines.
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Background
Over 500 million episodes of malaria occur yearly, pre-
dominantly in sub-Saharan African children under five
years of age, resulting in the death of approximately a mil-
lion of these children [1-3]. Severe anaemia due to
malaria occurs in 1.5 to 6.0 million African children per
year with a case fatality rate of about 10%; respiratory dis-
tress, hypoglycaemia and overlapping conditions contrib-
ute a further 1-2 million cases with a mortality of nearly
20% [4]. In Ghana, malaria has been [5], and remains the
first cause of loss of days of healthy life [6] as it accounts
for at least 20% of child deaths, 40% of child hospital
admissions and more than 50% of out-patient attend-
ances [6].
Knowledge of the epidemiology of malaria is essential for
the design and interpretation of the results of trials of
drugs, vaccines and other anti-malarial interventions [7-
10]. Information required includes data on parasite prev-
alence and parasite genetic characteristics, the dynamics
of the infection, attack rates, antigenic variability, the
nature, behaviour and genetic characteristics of the local
malaria vectors and information on patterns of morbidity
from malaria. Prior to the conduct of a series of drug and
vaccine trials, a study of the epidemiology of malaria were
carried out in a forest area of central Ghana, an area where
a few malaria studies have been done in recent years.
Methods
Study Site
Kintampo North and South districts lie within the forest-
savanna, transitional ecological zone in the Brong Ahafo
Region of Ghana. The districts have an area of 7,162 km2
and a population of approximately 150,000 living in 97
communities. The mean monthly temperature ranges
between 18°C and 38°C and the average rainfall is 1250
mm per annum, occurring mainly between May and
October each year.
Study participants selection
Three hundred and thirty-five children below five years of
age (child cohort) and 1,484 participants of all ages (all-
age cohort) from the study areas were enrolled. They came
from sixteen "index houses" selected randomly from the
22,000 houses within the study area that are registered in
a database of an ongoing health and demographic surveil-
lance system. The houses were stratified initially into three
micro-ecological areas (urban, rural savanna and forest)
and weighted such that the number of houses selected
from each of these areas was proportional to the target
population in each stratum and that only one "index
house" was selected from each village. From each "index
house", all children less than 10 years of age and a
weighted number of 10-19 years and above 19+ years old
adults were selected. If an "index house" did not have the
required number of participants per age group, nearby
houses were visited in order of proximity to the "index
house" until the required number for each age category
was obtained. An "index cluster", our unit of sampling,
formed the cluster of contiguous houses in which recruit-
ment took place. An average of 87 houses represented a
cluster. In total, there were 1113 participants in the age
group less than 10 years weighted in each cluster, 167 in
the 10-19 years age group and 204 participants in the 19+
years age-group. Study participants were recruited in
November and December 2003 and followed up over a
12-month period.
Active surveillance for incidence of clinical malaria
The child cohort was visited at home thrice weekly to
check the axillary temperature and to enquire about any
recent illness. If a child had an axillary temperature ≥
37.5°C or a history of fever within the past 48 hours as
reported by the caregivers, the symptoms and signs of the
illness were recorded and a finger-prick blood sample was
collected to measure haemoglobin concentration and to
prepare a blood smear. Children who had an axillary tem-
perature ≥ 37.5°C or a history suggestive of malaria and
malaria parasitaemia were treated with sulphadoxine-
pyrimethamine (SP), the second line drug for manage-
ment of uncomplicated malaria and allowed the clini-
cian's judgement to prevail. Participants were observed at
days 7, 14 and 28 post-treatment to assess clearance of
malaria parasites as well as resolution of symptoms. Chil-
dren who had a negative smear, had a repeat blood smear
taken on the following day and were treated with SP if
positive for malaria. If a repeat smear was negative and
symptoms had subsided, the thrice-weekly examination
of temperature and history taking was resumed. If symp-
toms persisted, daily temperature measurements, blood
smears and evaluation by the medical staff continued.
Symptomatic patients with negative smears were evalu-
ated for other conditions beside malaria, treated appropri-
ately and followed up. A referral system to the regional
hospital was put in place for any child whose condition
deteriorated.
Malaria Surveys
The all-age cohort was surveyed once every eight weeks
over the one- year study period. At each survey, axillary
temperature and a finger prick blood sample was collected
to measure haemoglobin concentration using a calibrated
haemocue (HaemoCue GmbH, Germany) and to test for
malaria parasites. A medical history was obtained and
physical examinations performed; information was also
collected on use of a bed net by each participant.
Examination of blood smears
Thin and thick blood smears were stained with Giemsa
after fixing the thin smear with methanol. At least 100Malaria Journal 2009, 8:220 http://www.malariajournal.com/content/8/1/220
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high power fields were examined before a thick smear was
declared negative. The number of parasites per micro-litre
approximately equals 40 times the number of parasites
counted per 200 leukocytes. 10% random selections of
smears were independently read by an experienced sec-
ond reader to ascertain the quality of microscopy. There
was a high level of correlation between the microscopists
(kappa = 0.94).
Polymerase Chain Reaction (PCR)
Baseline assessment of chloroquine and SP resistance
molecular markers and multiplicity of infection was car-
ried out. Parasite DNA was extracted using the Chelex 100
sodium form (Bio-Rad laboratories) according to the pro-
cedure previously described [11]. This DNA was used in
primary and secondary (nested) PCR analyses to detect
and characterize mutations in the Plasmodium falciparum
chloroquine resistance transporter (pfcrt) and multi-drug
resistance (pfmdr1) genes. Polymorphisms in the dihydro-
folate reductase (dhfr) and dihydropteroate synthase
(dhps) genes were also determined by nested PCR amplifi-
cations, and dot blot hybridization as previously
described by Noedl et al [12] and Duraisingh et al [13]. Pol-
ymorphic repetitive regions of block 3 of Merozoite Sur-
face Protein-2 (msp2) were used for genotyping the
Plasmodium falciparum isolates using a nested PCR.
The seasonal distribution of parasites within the all-age
cohort was determined in 600 participants microscopi-
cally positive for malaria. These randomly selected filter
paper samples were taken through DNA extraction and
analysis, using the chelex method and MSP2 genotyping
of Plasmodium falciparum as described above. Filtermats
were collected from children who were treated with SP for
clinical malaria episodes and actively followed up to
ascertain the treatment outcome. DNA was extracted from
filtermats with corresponding microscopically slide posi-
tive samples on the day of treatment (Day Zero), negative
on Day 14 and positive on Day 28 after treatment and
analysed using the methods developed and routinely used
at LSHTM [14,15] described above.
Estimation of malaria transmission using entomological 
inoculations rates
CDC light traps were used to collect mosquitoes in rooms
of randomly selected households. Trapping was done a
day before the malaria survey in each cluster. All houses
within the study area were given equal chances of partici-
pation. They were selected without replacement until all
houses within a stratified area had been considered. Traps
were set in at least four houses in each cluster each month.
Additional traps were set weekly in rooms of study partic-
ipants included in the child cohort or the all age cohort
ensuring that at least one trapping took place in each
month in each of the sixteen (16) clusters and throughout
the whole one year period of the study. A total of 664 suc-
cessful light traps were set in 708 houses. Occupants of
each room in which a trap was set were provided with an
untreated bed net to be used for the night that the trap was
set in his/her room. Traps were hung approximately 1.5 m
above the floor at the foot of the bed/mat of the index per-
son. Anopheline vectors were morphologically character-
ized by species using keys [16], stored in 1.5 ml micro-
centrifuge tubes enclosed in zip lock plastic bags with sil-
ica gel. A maximum of ten vectors of the same species
from the same compound was put in a tube. Non-Anophe-
lines were discarded after recording numbers caught.
Heads and thoraces of the two major vectors of malaria,
Anopheles gambiae and Anopheles funestus, were checked for
the presence of circumsporozoite (CS) antigens of Plasmo-
dium falciparum using the sandwiched Enzyme-Linked
Immunosorbent Assay (ELISA) as described by Wirtz et al
[17]. Presence of CSP in the mosquitoes was read at 405
nm wavelength using a micro plate ELISA reader. A cut-off
of 0.2 nm absorbance was considered positive after sub-
traction of an average value from seven negative test mos-
quitoes. Heads and thoraces of male Anopheles  vectors
were used as the negative test controls. All positive tested
mosquitoes were retested to confirm positives.
Sub-samples of An. gambiae species were subjected to PCR
analysis to identify sibling species within the complex as
per the Scott et al protocol [18]. Enzyme digestion to dif-
ferentiate the molecular forms of An. gambiae s.s. was per-
formed as per the protocol of Flavia et al [19]. The
presence of kdr alleles associated with knock-down resist-
ance in West Africa was assessed, as described in the Mar-
tínez-Torres  et al protocol [20]. An adjustment to
protocols for optimization and to suit local laboratory
conditions was done when necessary.
Sample size calculation
The sample size calculation was based on our assumed
estimates of the age-group specific parasite prevalence
rates (p) and standard error (s) among children less than
5 years (p = 84%, s = 0.03893), 5-10 years(p = 92%, s =
0.02845), 10-19 years (p = 64%, s = 0.05242), and more
than 19 years (p = 51%, s = 0.05242). A minimum
number of 140 volunteers was estimated in each age
group to represent a cluster. This allowed us to estimate
the age specific parasite prevalence rates to within 6 -10%
of the true values for the different age groups. The
expected precision of the estimates were calculated using
the formulae of Bennett et al [21].
Data management and statistical analysis
All data collected in the field or the laboratory were logged
for traceability, and then batched for double data entry
and processing using Microsoft® Visual FoxPro 6.0. AllMalaria Journal 2009, 8:220 http://www.malariajournal.com/content/8/1/220
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data management processes were done at the computer
laboratory of the Kintampo Health Research Centre. Data
analysis was done using StataCorp Stata 9, TX USA. Mov-
ing averages and proportions were used to provide
descriptions of age and seasonal variation in parasite prev-
alence, density, infection rates and the proportions of par-
asite clones that persisted over the period.
Ethical processes
The study protocol and instruments were reviewed and
approved by the Ghana Health Service Ethics Review
Committee and London School of Hygiene and Tropical
Medicine Ethics Committee. In each community, a meet-
ing was held among community members, their opinion
leaders and the investigators to seek approval for the study
to be conducted in the community before the study
started. Written consent was sought from each adult par-
ticipant while care-givers gave a written consent on behalf
of their children.
Results
Prevalence of malaria
The annual prevalence of malaria over the 12-month
period in the all-age cohort was 58% (95% CI: 56.9,
59.4%) and it ranged from 67.3% (95% CI: 64.1, 70.3%)
in May-June to 51.9% (95% CI: 49.3, 54.6%) in Novem-
ber-December. The average annual prevalence in children
below five years of age was 64% (95% CI: 61.9, 66.0%)
and it ranged from 74.3% (95% CI: 68.7, 79.3%) in May-
June to 56.8% (95% CI: 53.0, 60.5%) in November-
December, a statistically significant difference between
the two periods. Parasite prevalence increased with age
until about ten years. It was relatively high during the
rainy season (May-October) but was high throughout the
year (Figure 1). The geometric mean parasite density
(GMPD) decreased significantly with age but it remained
relatively constant throughout the year for all age groups
(Figure 2). There were no statistically significant differ-
ences between GMPDs within each age group throughout
the year.
Prevalence of anaemia
The mean haemoglobin concentration in the all-age
cohort was 10.67 g/dL. It was 10.64 g/dl in males and
10.71 g/dL in females. For the children under-five years of
age, the mean was 9.68 g/dL; children <2 year of age had
the lowest mean Hb concentration (8.85 g.dL) (Figure 3).
Throughout the year, over half of the children less than 10
years of age had a Hb < 11 g/dL (Figure 4). Moderately
severe anaemia (Hb <8 g/dL) was highest (12.6%) in
November/December, the end of the rainy season.
Incidence of clinical malaria
The incidence density of clinical malaria defined as any
level of parasite density plus reported fever/axillary tem-
perature > 37.5°C among children below five years of age
was 7 attacks per child per year. It was 2.3 attacks per year
in children below six months of age and peaked in 12-35
month old children (8.6 per child per year). The incidence
of malaria with higher parasite density levels was lower
than malaria with any parasite density in all age groups
(Table 1). The incidence of malaria in children below five
Parasite prevalence by age group and months of survey Figure 1
Parasite prevalence by age group and months of sur-
vey.
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years of age was higher in the rainy season compared to
the dry season. The prevalence of fever was significantly
higher when parasitaemia cut-off levels increased. For
children less than two years of age, incidence density with
parasite counts below 5,000/uL was 7.8 compared with
9.5 for parasite counts up to 10,000/μL and still higher
(11.3) for parasite counts up to 20,000/μL.
In vivo drug sensitivity of commonly used anti-malarials in 
the study area
For SP, the PCR uncorrected treatment failure rate by day
14 increased from 23.3% during a first recorded episode
to 40.3% when a child had a fourth or more frequent epi-
sode of malaria. Similarly, the treatment failure rate by
day 28 increased from 60.8% for first episodes to 79.8%
for the fourth or more episodes, suggesting a selection for
SP resistant parasites by repeated treatment (Table 2). The
adequate clinical and parasitological response for chloro-
quine on day 14 was 87.7% and for day 28 was 77.1%
(Table 3).
Molecular markers for chloroquine and SP resistance and 
multiplicity of infections
In a sample of 100 children from whom blood samples
were collected prior to treatment, the prevalence of muta-
tions at the pfcrt and pfmdr1 gene loci 76 and 86 were
62.2% and 60.1% respectively. The prevalence of muta-
tions at the pfdhfr gene loci 51, 59 and 108 were 51.3%,
66.2% and 60.9% respectively, while the prevalence of
mutations at the pfdhps gene locus 437 was 74.1%. There
were 31 isolates harbouring all three mutant alleles of pfd-
hfr gene. Twenty-five percent of the 31 isolates carried the
additional pfdhps A437G.
In keeping with the high prevalence of infection, the mul-
tiplicity of infections (MOI) was high. The MOI peaked in
March-April and this trend was seen in children and
adults (Figure 5).
Malaria vectors and entomological inoculation rate
A total of 19,835 mosquitoes were collected from light
trap catches during the one year study period and com-
prised  Culex  (51.3%),  Aedes  (1.0%),  Anopheles funestus
(35.2%),  Anopheles gambiae (10.6%),  Anopheles rufipes
(1.8%) and Anopheles pharoensis (0.1%). Among the sam-
ple of mosquitoes assayed by CS-ELISA, 1.5% of An. funes-
tus (n = 6,542) and 4.7% of An. gambiae (n = 1,876) were
infected with P. falciparum. No An. arabiensis was found.
The estimated annual Entomological Inoculation Rate
(EIR) for both An. gambiae and An. funestus vector species
was 269 infective bites per person per year (ib/p/y). Infec-
tive bites per person per night ranged from 0-13.5 in the
communities (Figure 6). There were variations in EIRs by
season and between clusters. EIR peaked during the minor
wet season, Nov - April (202 ib/p/y) and became less dur-
ing the major wet season, May-Oct (67 ib/p/y). Transmis-
sion was all-year round, but the two main vectors
alternated their peak transmission periods (Figure 7). An.
gambiae transmission peaked at the end of the rainy sea-
son (November to December) whiles An. funestus trans-
mission peaked during the rains (May to October). This
observation reflected in abundance of the vectors as the
abundance of An. gambiae was very high at the end of rains
Mean haemoglobin concentration by age and month of sur- vey Figure 3
Mean haemoglobin concentration by age and month 
of survey.
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Table 1: Incidence density of clinical malaria* by age group in under five year-old children
Age group Episodes of clinical malaria Person Years Incidence density (no. of episodes per child per year)
Any Parasitaemia
0-6 mth 36 5637 2.3
0-11 mth 145 12301 4.3
12-23 mth 310 13239 8.6
24-35 mth 246 10618 8.5
36-47 mth 224 11673 7.0
48-59 mth 133 7658 6.3
under-five yrs 1058 55489 7.0
Parasitaemia >5000/μL
0-6 mth 12 5637 0.8
0-11 mth 77 12301 2.3
12-23 mth 222 13239 6.1
24-35 mth 166 10618 5.7
36-47 mth 122 11673 3.8
48-59 mth 69 7658 3.3
under-five yrs 656 55489 4.3
Parasitaemia >10000/μL
0-6 mth 9 5637 0.6
0-11 mth 62 12301 1.8
12-23 mth 193 13239 5.3
24-35 mth 145 10618 5.0
36-47 mth 103 11673 3.2
48-59 mth 56 7658 2.7
under-five yrs 559 55489 3.7
Parasitaemia >20000/μL
0-6 mth 7 5637 0.5
0-11 mth 45 12301 1.3
12-23 mth 146 13239 4.0
24-35 mth 108 10618 3.7
36-47 mth 80 11673 2.5
48-59 mth 46 7658 2.2
under-five yrs 425 55489 2.8
Parasitaemia >50000/μL
0-6 mth 1 5637 0.1
0-11 mth 27 12301 0.8
12-23 mth 80 13239 2.2
24-35 mth 61 10618 2.1
36-47 mth 32 11673 1.0
48-59 mth 16 7658 0.8
under-five yrs 216 55489 1.4
* Clinical malaria = parasitemia at defined levels plus either temperature ≥ 37.5°C or reported fever within 48 hoursMalaria Journal 2009, 8:220 http://www.malariajournal.com/content/8/1/220
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whiles abundance of An. funestus was very high during the
torrential rains (Figure 7). Nonetheless, An.  gambiae
remained the main vector contributing most to transmis-
sion despite the lower abundance of this vector popula-
tion within the survey period. There were marked
variations in EIR between communities, depicting the het-
erogeneity of the micro-ecology in the forest-savanna
fringes of Ghana. Monthly fluctuations in vector densities
resulted in variations in inoculation rates by season (Fig-
ure 7). Inoculation rates were however sustained through-
out the year by the two main vectors.
Species, molecular forms and knock-down resistance (kdr)
Only Anopheles gambiae s.s were caught and identified as
the predominant Plasmodium falciparum vector; 55 of the
species were randomly selected and tested using molecu-
lar techniques. In the wet season samples, DNA was
amplified successfully in 22 of which 16 (88.89%) were
identified as S-molecular forms, two (11.11%) as M-
molecular forms and one (5.56%) as a hybrid (S-M)
molecular form. The pattern was similar for 33 samples
collected in the dry season where 11 (68.75%) were made
up of S-molecular forms, two (12.50%) of the M-molecu-
lar forms and three (18.75%) were hybrids (S-M)-molec-
ular forms (Table 4). The frequency of kdr  resistant
genotypes was 0.60 F(R). The genotypes kdrRR  was
observed in the M-molecular form in comparison with the
kdrR/S genotype which was found in the hybrid (M-S)
molecular form. All susceptible genotypes kdrS/S  were
detected in S-molecular forms (Table 4).
Bed net (treated or untreated) use was low for all age
groups. The maximum use of a bed net was found among
children less than 5 years of age (25.4%). However, <10%
of the community used treated bed nets throughout the
year.
Discussion
The prevalence of malaria is now falling in several parts of
Africa [22-25] as the result of scaling up of control inter-
ventions such as insecticide-treated bed nets (ITNs) and
artemisinin-based combination therapy (ACT) [26,27].
However, this study shows that in the year 2004 the bur-
den of malaria was still very high in the forest/savanna
transition of central Ghana. The clinical malaria attack
rate and prevalence of malaria in children were very high.
The prevalence of anaemia was very high and consistent
with reports in Ghana (84%) [28] and other African coun-
tries [29] where malaria was endemic. The high preva-
lence of anaemia could also be due to malnutrition,
hookworm infection, and sickle cell anaemia. However,
the contribution of these illnesses to anaemia in a malaria
endemic region has been found to be minimal compared
malaria [30,31]
The average EIR (269 ib/p/y) was also relatively high and
transmission was mainly by Anopheles gambiae and Anoph-
eles funestus. An arabiensis had no role in malaria transmis-
sion in this area unlike other West-African countries such
as Mali [32]. This could be due to the short duration of the
dry season in our study area compared to the long dura-
tion of dry season in Mali. A similar environmental influ-
ence on species survival is demonstrated by the molecular
Table 2: Proportion of children with malaria parasites within 28 days post treatment with sulphadoxine-pyrimethamine at each 
episode of malaria
Day of follow up First episode Second episode Third episode Four or more episodes
(N = 288) (N = 237) (N = 183) (N = 382)
7 24.3 22.8 20.8 29.3
14 23.3 27.0 35.5 40.3
28 60.8 61.2 73.2 79.8
Table 3: Proportion of children with malaria parasitaemia within 
28 days post treatment with chloroquine
Day of follow up first episode
(N = 455)
74 . 2
14 12.3
28 22.9
Mean Multiplicity of Infections by season (MOI) Figure 5
Mean Multiplicity of Infections by season (MOI).
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forms of An. gambiae s.s. The S-molecular form was pre-
dominant in this area with a short dry season contrary the
predominantly M-form found in northern Ghana where
the dry season is longer [33]. The presence of low fre-
quency of hybrids suggests the possibility of interbreeding
and gradual gene flow within the complex.
A number of factors are likely to underlie the reason why
the burden of malaria has remained so high in this part of
Ghana despite its relatively high level of prosperity and
well-functioning health system. Firstly, the ecosystem is
well suited to the survival of An. gambiae and An. funestus
with many suitable breeding sites for both species and
high humidity persisting throughout the year. Secondly,
at the time of this study, attempts at vector control in the
area were limited. Coverage with ITNs was low and less
than 10% of the community members used ITNs through-
out the year and no indoor residual spraying was taking
place. This low coverage was similar to most other rural
areas of Ghana where ITNs coverage was on the average
about 3.5% in 2003 as reported in the Ghana Demo-
graphic and Health Survey. Thirdly, at the time of the
study, clinical malaria was being treated in government
facilities and in the private sector primarily with chloro-
quine or SP. This study demonstrated a high treatment
failure rate with both of these drugs, and a high preva-
lence of mutations associated with resistance to each of
these drugs similar to other reports in Ghana [34].
Following from the results in this study, steps have been
taken to strengthen malaria control in the study area. Use
of ITNs has been actively promoted through education
and free ITNs distribution. The use of ITNs has increased
to 60% among children less than 5 years and pregnant
women in 2007 (Kintampo Health and Demographic Sur-
veillance Systems updates). Since 2005, the first line treat-
ment for malaria has been changed from chloroquine and
SP to the more effective drug combination of artesunate
plus amodiaquine, although other anti-malarials are still
used in the private sector. It is likely that as a result of
these interventions the level of malaria transmission has
fallen in the study area since the investigations reported in
this paper were carried out and therefore a follow-up sur-
vey needs to be undertaken. Nevertheless, in comparison
to many other parts of Africa, the transmission of malaria
remains high in this zone because the background inci-
dence of malaria in children was very high and there is
transmission throughout the year. Thus, the Kintampo
area is an appropriate site for the conduct of malaria treat-
ment and vaccines trials. Since the completion of this
study a clinical trial of artemether-lumefantrine, amodi-
aquine and artesunate and artesunate + chlorproguanil
dapsone [35] and two phase II trials of the malaria vaccine
RTS, S have been carried out.
Conclusion
Findings from this study have facilitated the design of tri-
als of anti-malarial drugs and vaccines in the study area
Mean Sporozoite Rates (SR) in communities in Kintampo Figure 6
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Table 4: Species, molecular forms and kdr genotypes in An. gambiae s.s in Kintampo
Species Molecular forms Kdr mutation
Season Ag. Ar. M M/S S kdrRR kdrR/S kdrSS F(R)
Wet 22 0 2 1 16 3 1 1 0.60
Dry 33 0 2 3 11 3 1 1
Hardy-Weinberg expected frequencies not significantly different (P < 0.05; df = 1; χ2 = 0.005)Malaria Journal 2009, 8:220 http://www.malariajournal.com/content/8/1/220
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and led to optimal interpretation of the results from such
trials. On the basis of the background epidemiology of
malaria described in this paper, the Kintampo Health
Research Centre is well-equipped to contribute to the
phase 3 trial of the RTS, S vaccine starting in mid-2009
and future treatment and vaccine trials.
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